AGI-5198

CAS No. 1355326-35-0

AGI-5198 ( (IDH-C35) )

Catalog No. M11453 CAS No. 1355326-35-0

AGI-5198 is the first highly potent and selective inhibitor of IDH1 R132H/R132C mutants with IC50 of 0.07 μM/0.16 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 29 In Stock
10MG 47 In Stock
50MG 69 In Stock
100MG 113 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    AGI-5198
  • Note
    Research use only, not for human use.
  • Brief Description
    AGI-5198 is the first highly potent and selective inhibitor of IDH1 R132H/R132C mutants with IC50 of 0.07 μM/0.16 μM.
  • Description
    AGI-5198 is the first highly potent and selective inhibitor of IDH1 R132H/R132C mutants with IC50 of 0.07 μM/0.16 μM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    (IDH-C35)
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Dehydrogenase
  • Recptor
    R132C-IDH1| R132H-IDH1
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1355326-35-0
  • Formula Weight
    462.57
  • Molecular Formula
    C27H31FN4O2
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 14 mg/mL (30.26 mM); DMSO: 24 mg/mL (51.88 mM)
  • SMILES
    O=C(NC1CCCCC1)C(N(C2=CC=CC(F)=C2)C(CN3C=CN=C3C)=O)C4=CC=CC=C4C
  • Chemical Name
    N-cyclohexyl-2-(N-(3-fluorophenyl)-2-(2-methyl-1H-imidazol-1-yl)acetamido)-2-(o-tolyl)acetamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Rohle D, et al. Science, 2013, 340(6132), 626-630.
molnova catalog
related products
  • G6PDi-1

    G6PDi-1 is an effective G6PD inhibitor. It depletes NADPH and decreases inflammatory cytokine production. G6PDi-1 effectively inhibits G6PD.?

  • NSC 14613

    PluriSln 1(NSC 14613) is an inhibitor of stearoyl-coA desaturase (SCD1), the key enzyme in oleic acid biosynthesis, revealing a unique role for lipid metabolism in hPSCs.

  • BI-4916

    BI-4916 is a selective phosphoglycerate dehydrogenase (PHGDH) inhibitor that inhibits SSP and reduces the migration of cancer cells.BI-4916 can be used in the study of cancer and metabolic diseases.